Volume 6, Issue 1 pp. 35-37
Original Article
Full Access

Coxsackie B virus assays in IDDM families: The GAW5 data on antibody prevalence

Dr. J. W. Yoon

Corresponding Author

Dr. J. W. Yoon

Faculty of Medicine, The University of Calgary, Calgary, Alberta, Canada

Department of Microbiology and Infectious Diseases, Faculty of Medicine, The University of Calgary, 3330 Hospital Drive N.W., Calgary, Alberta, Canada T2N 4N1Search for more papers by this author
K. W. Kim

K. W. Kim

Faculty of Medicine, The University of Calgary, Calgary, Alberta, Canada

Search for more papers by this author
H. M. Kim

H. M. Kim

Faculty of Medicine, The University of Calgary, Calgary, Alberta, Canada

Search for more papers by this author
C. Y. Pak

C. Y. Pak

Faculty of Medicine, The University of Calgary, Calgary, Alberta, Canada

Search for more papers by this author
Y. W. Kim

Y. W. Kim

Faculty of Medicine, The University of Calgary, Calgary, Alberta, Canada

Search for more papers by this author
R. G. McArthur

R. G. McArthur

Faculty of Medicine, The University of Calgary, Calgary, Alberta, Canada

Search for more papers by this author
First published: 1989
Citations: 6

Abstract

There is evidence that infection by Coxsackie viruses can serve as an environmental “trigger” for insulin-dependent diabetes mellitus (IDDM). This background information is summarized briefly, and the data in the IDDM component of Genetic Analysis Workshop 5 (GAW5) concerning serum antibodies to Coxsackie B viruses are described.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.